HOME >> MEDICINE >> NEWS
Children's Hospital Oakland opens new $5.6 million infectious disease lab

a few blocks north of the hospital. This new unit consists of interactive laboratories and office spaces, as well as specialized, shared facilities such as a DNA clean room and a biological safety level-3 facility (BL-3), which is one of the highest safety and security standards for this type of medical research.

"The CIVD's BL-3 status means that when we constructed this laboratory we had to meet some of the highest safety standards established by the National Institutes of Health (NIH) and the Center for Disease Control and Prevention (CDC)," said Alex Lucas, Ph.D., deputy director of CHORI. "The end result is that we are better equipped to expand our research capabilities to design and improve vaccines in ways we never could before."

CHORI was awarded a $2 million construction grant from the National Center for Research Resources (NCRR) at the NIH to build the CIVD. Dr. Lucas was the principal investigator on this grant. The remaining funds were secured through individual donations and large financial gifts from the philanthropic community.

CHORI's operating budget in 2005 is $48 million, which is generated through extramural grants obtained by scientists and clinicians. The awards CHORI scientists received placed CHORI 14th out of 113 children's hospitals and pediatric departments in the United States, according to data provided by The National Association of Children's Hospitals in their most recent survey.


'"/>

Contact: Venita Robinson
vrobinson@mail.cho.org
510-428-3069
Children's Hospital & Research Center at Oakland
3-Feb-2005


Page: 1 2

Related medicine news :

1. Sleeping Through the Night: Childrens sleep expert advises parents
2. Surgeon General at Childrens Hospital & Research Center at Oakland
3. Brenner Childrens Hospital named to NIH Pediatric Heart Network
4. Childrens Hospital at Vanderbilt ranked 8th in nation by Child magazine
5. Childrens anxiety prior to surgery linked to behavioral changes
6. Texas Childrens Hospital specialists say proactive approach best defense against flu season
7. Texas Childrens Hospital jumps up in list of Americas Best
8. NIH awards Baylor, Texas Childrens No. 1 spot in pediatric-research funding
9. Researchers at Cincinnati Childrens link a strain of E. coli to diarrhea in children
10. Texas Childrens Hospital implants first MicroMed/DeBakey child ventricular assist device
11. Childrens genetic factors determine HIV progression according to UCSD study

Post Your Comments:
(Date:7/23/2014)... The routine use of a molecular ... likelihood of performing the correct initial surgery for ... from the University of Pittsburgh Cancer Institute (UPCI), ... at the UPMC/UPCI Multidisciplinary Thyroid Center and other ... getting the correct initial surgery by 30 percent, ...
(Date:7/23/2014)... FL (PRWEB) July 23, 2014 Men ... pay higher premiums for life insurance based on national ... cheap life insurance rates search to its comprehensive tool ... at http://quotespros.com/life-insurance.html . , Providers that are ... selected, sorted and reviewed in one or two clicks. ...
(Date:7/23/2014)... near Sellafield or Dounreay since the 1990s are not ... research published in the British Journal of Cancer ... Research Group at the University of Oxford and from ... among those who were under 25 and living near ... in cancer incidence from 1991-2006 between those living near ...
(Date:7/23/2014)... New York, New York (PRWEB) July 23, 2014 ... that the use of a power morcellator ( http://www.injurybeacon.com/power-morcellator/ ... uterine sarcoma and other cancers throughout a woman’s body, ... on July 22nd in the Journal of the American ... hysterectomy using a power morcellator at 500 U.S. hospitals ...
(Date:7/23/2014)... Asking patients if a suspicious skin lesion is ... spot is likely to be cancerous, according to a ... the Department of Dermatology at Temple University School of ... Dermatology on July 23, 2014, found that nearly ... by itching, while 28.2 percent involve pain. Non-melanoma skin ...
Breaking Medicine News(10 mins):Health News:UPMC-Developed Test Increases Odds of Correct Surgery for Thyroid Cancer Patients 2Health News:UPMC-Developed Test Increases Odds of Correct Surgery for Thyroid Cancer Patients 3Health News:UPMC-Developed Test Increases Odds of Correct Surgery for Thyroid Cancer Patients 4Health News:Cheap Life Insurance Rates for Married Couples Added to Search System at Insurer Portal Online 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Publication of New Study Confirming Potential for Uterine Morcellation to Spread Undetected Cancer 4Health News:Research led by Temple's chair of dermatology: Pain and itch may be signs of skin cancer 2
(Date:7/23/2014)...  Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a ... expertise in opioid antagonists, announced today that it ... with respect to its naloxone-based opioid overdose reversal ... has received an additional commitment from the National ... National Institutes of Health ("NIH"), to fund a ...
(Date:7/23/2014)... CITY, Calif. , July 23, 2014  Cardica, Inc. ... release financial results for its fiscal fourth quarter and year ... the markets close. Cardica,s management will host a conference call ... and provide an update on the company,s business. ... August 7, 2014, at 4:30 p.m. Eastern Time via phone, ...
(Date:7/23/2014)... Colo. , July 23 2014 Ampio ... of its new headquarters, manufacturing and research facility: ... CO 80112 Direct: (720) 437-6500 ... labor efficient, pharmaceutical drug manufacturing facility will be fully ... produce the first batches of Ampion TM necessary ...
Breaking Medicine Technology:Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 3Cardica to Announce Fiscal 2014 Fourth Quarter and Full Year Financial Results on Thursday, August 7, 2014 2Ampio Pharmaceuticals announces the opening of its new headquarters, manufacturing and research facility in Englewood Colorado 2
Cached News: